BIO-TECHNE Corp — Director's Dealing 2023

Aug 24, 2023

SEC Form 4/A — Form 4/A

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-08-15

Reporting Person: Bohnen Shane (SVP - General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-15	Restricted Stock Units	$	A	148	Acquired		Common Stock (148)	Direct
2023-08-15	Stock Option (Right to Buy)	$84.61	A	16302	Acquired	2030-08-15	Common Stock (16302)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	135	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: 49 restricted stock units vest on each of 8/15/2024 and 8/15/2026, and 50 restricted stock units vest on 8/15/2025.

F3: This grant was previously reported as options to purchase 15,904 shares. This amendment reflects the corrected number of stock options granted.

F4: Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027.